Article ; Online: N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial.
Neurological research and practice
2021 Volume 3, Issue 1, Page(s) 29
Abstract: Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen ...
Abstract | Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen utilization by tissue and complex with free radicals. Beneficial effects are improved endurance performance and reduction fatigue in humans and animals. This pilot study reports the results over a one-year double-blind, placebo-controlled trial of DMG in 30 randomized patients with progressive multiple sclerosis. No treatment effects were found between the placebo group and the DMG group for disability, fatigue, cognitive, or gait parameters. |
---|---|
Language | English |
Publishing date | 2021-05-24 |
Publishing country | England |
Document type | Letter |
ISSN | 2524-3489 |
ISSN (online) | 2524-3489 |
DOI | 10.1186/s42466-021-00126-z |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.